SHSE:603896 (China)
Â
Class A
Â¥
21.82
(-0.09%)
Nov 28
Business Description
Zhejiang Shouxiangu Pharmaceutical Co Ltd
ISIN : CNE100002XJ4
Share Class Description:
SHSE:603896: Class ACompare
Compare
Traded in other countries / regions
603896.China IPO Date
2017-05-10Description
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.96 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 2.43 | |||||
| Interest Coverage | 18.86 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.59 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year EBITDA Growth Rate | 17.1 | |||||
| 3-Year EPS without NRI Growth Rate | 15.5 | |||||
| 3-Year Book Growth Rate | 16 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.46 | |||||
| 9-Day RSI | 45.71 | |||||
| 14-Day RSI | 47.4 | |||||
| 6-1 Month Momentum % | -14.87 | |||||
| 12-1 Month Momentum % | -37.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.05 | |||||
| Quick Ratio | 3.48 | |||||
| Cash Ratio | 3.07 | |||||
| Days Inventory | 509.32 | |||||
| Days Sales Outstanding | 54.37 | |||||
| Days Payable | 356.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.79 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| 3-Year Dividend Growth Rate | 18.4 | |||||
| Forward Dividend Yield % | 1.79 | |||||
| 5-Year Yield-on-Cost % | 5.42 | |||||
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | 2.79 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.37 | |||||
| Operating Margin % | 26.85 | |||||
| Net Margin % | 32.76 | |||||
| FCF Margin % | -42.82 | |||||
| ROE % | 10.7 | |||||
| ROA % | 7.52 | |||||
| ROIC % | 11.4 | |||||
| ROC (Joel Greenblatt) % | 29.86 | |||||
| ROCE % | 9.35 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.34 | |||||
| Forward PE Ratio | 14.04 | |||||
| PE Ratio without NRI | 19.16 | |||||
| Shiller PE Ratio | 26.29 | |||||
| PEG Ratio | 0.97 | |||||
| PS Ratio | 6.01 | |||||
| PB Ratio | 1.94 | |||||
| Price-to-Tangible-Book | 2.31 | |||||
| Price-to-Operating-Cash-Flow | 16.26 | |||||
| EV-to-EBIT | 15.4 | |||||
| EV-to-EBITDA | 15.4 | |||||
| EV-to-Revenue | 5.27 | |||||
| EV-to-FCF | -12.34 | |||||
| Price-to-Projected-FCF | 1.86 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.91 | |||||
| Price-to-Graham-Number | 1.4 | |||||
| Price-to-Net-Current-Asset-Value | 6.08 | |||||
| Price-to-Net-Cash | 12.69 | |||||
| Earnings Yield (Greenblatt) % | 6.49 | |||||
| FCF Yield % | -7.07 | |||||
| Forward Rate of Return (Yacktman) % | 20.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Shouxiangu Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 713.753 | ||
| EPS (TTM) (Â¥) | 1.19 | ||
| Beta | 1.13 | ||
| Volatility % | 39.13 | ||
| 14-Day RSI | 47.4 | ||
| 14-Day ATR (Â¥) | 0.607435 | ||
| 20-Day SMA (Â¥) | 22.206 | ||
| 12-1 Month Momentum % | -37.28 | ||
| 52-Week Range (Â¥) | 18.49 - 37.05 | ||
| Shares Outstanding (Mil) | 198.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Shouxiangu Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Shouxiangu Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Shouxiangu Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896)'s stock price today?
The current price of SHSE:603896 is ¥21.82. The 52 week high of SHSE:603896 is ¥37.05 and 52 week low is ¥18.49.
When is next earnings date of Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896)?
The next earnings date of Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896) is .
Does Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896) is 1.79% (As of Today), Highest Dividend Payout Ratio of Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896) was 0.38. The lowest was 0.24. And the median was 0.31. The  Forward Dividend Yield % of Zhejiang Shouxiangu Pharmaceutical Co Ltd(SHSE:603896) is 1.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers